clinical trial · NCT07774325
A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood
HealthyBI 3000202CiclosporinItraconazole
brief summary
The main objective of this trial is to investigate the effects of multiple doses of Itraconazole and multiple doses of Ciclosporin on the pharmacokinetics of BI 3000202 in plasma following a single oral dose in healthy male trial participants.
started
Sep 1, 2026
primary completion
Feb 21, 2027
completion
Mar 8, 2027
last updated
Nov 12, 2026
official title
The Effects of P-gp Inhibition and OATP Inhibition on the Pharmacokinetics of a Single Oral Dose of BI 3000202 in Healthy Male Trial Participants (an Open-label, Three-period, Two-sequence Crossover Trial, With Period 3 as Fixed Treatment)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol